	Risk Group Stratification for True Early Recurrence After Ablation for Hepatomas. Can J Gastroenterol Hepatol Yen YH, Kee KM, Hung CH, Chen CH, Hu TH, Wang JH, Lu SN. PMID: 42365457 [PubMed - indexed for MEDLINE]
	Diagnostic Performance of Serum AKR1B10 in Early-Stage and AFP-Negative Hepatocellular Carcinoma: A Multicentre Study. Liver Int Cao Z, Xie M, Ye X, Wu B, Wang H, Chen G, Cao D, Wang B, Zeng X, Sun Z. PMID: 42363436 [PubMed - indexed for MEDLINE]
	Feasibility Study of Combined Systemic Therapy and Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Patients. Cancer Med Kobayashi D, Shibuya K, Miyasaka Y, Araki K, Yamazaki Y, Shirabe K, Ohno T. PMID: 42363399 [PubMed - indexed for MEDLINE]
	Comprehensive analysis of the RBP regulome reveals functional modules and drug candidates in liver cancer. Sci Rep Garbulowski M, Mosca R, Gallardo-Dodd CJ, Kutter C, Sonnhammer ELL. PMID: 42362666 [PubMed - indexed for MEDLINE]
	Chromatin chronicles: Unlocking the therapeutic potential of histone modifiers in hepatocellular carcinoma. Med Oncol Sulaiman M, Chen Z, Nie Y, Hani UE, Raza F, Mulumba J, Zhang Z, Yang M, Yuan S, Sun C. PMID: 42360649 [PubMed - indexed for MEDLINE]
	Prediction of Ki-67 expression in hepatocellular carcinoma: a dual-center study based on T2-weighted imaging habitat analysis. Radiol Oncol Zheng X, Huang L, Huang M, Yu B, Qin S, Huang D. PMID: 42359754 [PubMed - indexed for MEDLINE]
	Colorectal cancer liver metastasis: immunosuppressive microenvironment, signaling pathways, and emerging therapeutic strategies. Front Immunol Yang H, Wu S, Chen L. PMID: 42358994 [PubMed - indexed for MEDLINE]
	Application of immune checkpoint inhibitors in hepatocellular carcinoma: a landscape analysis of clinical trial databases. Front Immunol Cao J, Chen Y, Zhang L, Lou J, Li S, Wen H, Huang R, Ma L. PMID: 42358968 [PubMed - indexed for MEDLINE]
	Preclinical Models of Colorectal Cancer Liver Metastasis: Therapeutic Evaluation and Translational Implications. Oncol Res Han YR, Lee SB. PMID: 42358838 [PubMed - indexed for MEDLINE]
	Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications. Oncol Res Yu G, Ge W, Yao H, Bai X, Wu J, Wang Y, Bai J, Cui Y, Han J. PMID: 42358827 [PubMed - indexed for MEDLINE]
	Diet-Microbiota-Immune Interactions in Hepatocellular Carcinoma: An Immunometabolic and Spatial Perspective. Nutrients Salem AE, Nassar N, Emam SM, Negm SH, Talib WH, Raposa B. PMID: 42356299 [PubMed - indexed for MEDLINE]
	Deubiquitinating Enzymes as Therapeutic Candidates in Hepatocellular Carcinoma and Other Liver Disease. Int J Mol Sci Jeong YH, Lee HH, Kim YJ, Lee HR, Lim KH. PMID: 42353339 [PubMed - indexed for MEDLINE]
	Circulating Cell-Free DNA Analysis for Diagnostic and Prognostic Assessment of Hepatocellular Carcinoma in Cirrhosis. Int J Mol Sci Aznar-Peralta I, Roa-Colomo A, López Hidalgo J, Fresno C, Denninghoff V, José Serrano M. PMID: 42353299 [PubMed - indexed for MEDLINE]
	Understanding the Predictors of Self-Perceived Burden in Patients With Liver Cancer. Nurs Health Sci Liu B, Chu D, Soh KL, Sun C, Saidi HI, Yubbu P, Japar S. PMID: 42349868 [PubMed - indexed for MEDLINE]
	Radiotherapy for Adrenal Metastases from Hepatocellular Carcinoma: A 20-Year Bi-Institutional Experience. Curr Oncol Lee J, Kim M. PMID: 42346228 [PubMed - indexed for MEDLINE]
	Cancer Detection and Surveillance Pathways with Abbreviated MRI in the Prostate, Pancreas, and Liver: A Risk-Stratified Narrative Review. Curr Oncol Brown H, Clarke SE. PMID: 42346206 [PubMed - indexed for MEDLINE]
	Immunotherapy and Hepatocellular Carcinoma: From Tumor-Immune Cell Interactions to Rational Therapeutic Strategies. Cells Yuza K, Pawlik TM. PMID: 42346124 [PubMed - indexed for MEDLINE]
	HCC-miR: A Simple, Noninvasive, and Sensitive Model for Early Diagnosis of HCV-Associated Hepatocellular Carcinoma. Asian Pac J Cancer Prev Ayad M, Saleh H, El-Mezayen HA, El-Kassas M, El-Sharkawy A. PMID: 42345172 [PubMed - indexed for MEDLINE]
	Postoperative Abscesses in the Liver Resection Plane in Patients with a History of Biliary Tract Treatments: A Multicenter Cohort Study. Asian Pac J Cancer Prev Iida H, Shinkawa H, Kosaka H, Ueno M, Mori H, Komeda K, Yasuda S, Kinoshita M, Hayami S, Tani M, Kaibori M, Kubo S. PMID: 42345150 [PubMed - indexed for MEDLINE]
	From dysbiosis to malignancy: decoding gut-driven pathways to clinical management in hepatocellular carcinoma. Front Cell Infect Microbiol Ismaiel A, Almonajjed MB, Wardeh M, Abdelghafar A, Popa SL, Sabo C, Dumitrascu DL. PMID: 42345020 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 76700

Page 1 of 3835



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy